Devyser’s Prenatal Chromosome Test Gets IVDR Certification
Devyser Compact is a rapid genetic test for prenatal chromosome testing and is approved under the new more comprehensive regulation.
Read MorePosted by Andy Lundin | Mar 1, 2023 | Prenatal Testing |
Devyser Compact is a rapid genetic test for prenatal chromosome testing and is approved under the new more comprehensive regulation.
Read MorePosted by Andy Lundin | Feb 24, 2023 | Womens Health |
Women who developed mood and anxiety disorders related to pregnancy and childbirth had altered proteins circulating in their bloodstream.
Read MorePosted by Andy Lundin | Feb 17, 2023 | Unknown Origin & Other Cancer Types |
Black patients are less likely to receive early diagnoses for uterine cancer than other racial and ethnic groups, according to new research.
Read MorePosted by Andy Lundin | Feb 17, 2023 | Breast |
Natera’s Signatera MRD test has met coverage requirements for adjuvant and recurrence monitoring in patients with breast cancer.
Read MorePosted by Andy Lundin | Feb 16, 2023 | Cancer |
Eurofins launched a test that can assess the expansion and persistence of CAR-T therapy in patients with certain leukemia and lymphomas.
Read More